PATH Stock Slips As RBC Slashes Price Target

UiPath Inc. stocks have been trading down by -7.86 percent amid bearish sentiment over automation demand and competitive pressure.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

RBC Capital cut UiPath’s price target from $14 to $12 while keeping a Sector Perform rating.
The firm flagged execution risk, weak non-seed pricing, and unclear AI benefits as key concerns for PATH.
RBC also pointed to negative job posting trends ahead of Q1, hinting at softer demand.
Street consensus on UiPath still sits at a hold, with an average target of $13.67 despite RBC’s lower view.

Live Update At 12:33:48 EDT: On Tuesday, June 02, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -7.86%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

UiPath Inc. and ticker PATH are trading in a short-term uptrend, but with a clear overhang. Over the past few weeks, PATH has climbed from a close near $9.50 to the $12 area, a move of roughly 25%. That is a strong bounce, but it comes after heavy prior selling and now runs into new Wall Street skepticism.

Daily data show PATH grinding higher in a stair-step pattern: higher lows from around $9.44 up through $12.05. Intraday, today’s 5‑minute chart shows a gap up near $12.40 premarket, a push to $12.77, and then fading back toward $12.05. That’s classic “pop and fade” action, signalling active selling into strength.

More Breaking News

On the fundamentals, UiPath generated about $4.81B in annualized revenue run-rate from the latest quarter, with revenue growth of more than 15% over three years and over 20% over five years. Gross margin is a hefty 83.2%, which tells traders PATH has a high‑value software model. The company is now GAAP profitable with $104.46M in net income last quarter and positive free cash flow of about $179.30M. Balance sheet leverage is very low, with total debt to equity near 0.03 and a current ratio of 2.5, so liquidity is not the problem.

Why Traders Are Watching PATH After RBC’s Cut

Traders are glued to PATH today because of a clear message from RBC Capital: slow down your expectations. RBC cut its UiPath price target from $14 to $12, while keeping a Sector Perform rating. In plain English, PATH stays a “hold-type” name, but the upside bar has been lowered. For an AI automation story that has lived on hype before, that matters.

RBC’s note focused on execution. They want to see several quarters of consistent results from UiPath before getting more bullish. For active traders, that reads like: “this will be a grind, not a sprint.” PATH has been trying to prove it can convert its huge gross margin into steady earnings, not just one strong quarter.

The pricing issue is another big flag. RBC called out the need for better non-seed pricing progress. That speaks to how UiPath monetizes beyond initial licenses — the expansion seats and add-ons that drive real SaaS scaling. If PATH struggles there, growth may look fine at the top line, but unit economics could disappoint over time.

RBC also highlighted unclear AI-driven benefits and negative job posting trends ahead of Q1. That combination suggests demand might be slowing just as everyone is talking about AI automation. For traders, that disconnect is key: PATH is an AI narrative stock, but the data RBC sees in hiring and customer signals is not screaming “boom.” Add in that the Street’s broader consensus is only a hold with an average target of $13.67, and you have a name many funds will treat as “prove it first.” That sets the stage for sharp moves around each earnings print and headline.

Conclusion

PATH sits at an interesting crossroads. Price action shows a solid short-term bounce and decent liquidity, while fundamentals are finally tilting toward sustainable profitability and strong free cash flow. UiPath’s 83.2% gross margin and low debt give the company real staying power in automation and AI software. On paper, it has the resources to execute.

But traders cannot ignore the tone from RBC. Cutting the UiPath price target to $12, below the $13.67 consensus, and stressing execution risk, pricing challenges, and weak job posting trends sends a clear caution flag. PATH is not being treated like a high‑conviction AI leader yet. It is being treated like a show‑me story that needs multiple clean quarters.

For active traders in the Tim Sykes community, that combination often translates to a reactive trading plan: respect the trend, but be ready for traps. Breakouts in PATH can fail fast if Q1 numbers or commentary don’t match the AI hype. At the same time, oversold dips may offer sharp bounce trades because the balance sheet is strong and the business is not broken. As Tim Sykes loves to remind traders, “React, don’t predict — let the price action confirm your thesis before you size up.” That pairs well with the process‑focused approach echoed by other educators; as Tim Bohen, lead trainer with StocksToTrade says, “A consistent trading routine beats sporadic action every time. Show up daily, and you’ll start to see the patterns others miss.” With UiPath and ticker PATH, that mindset is exactly what this kind of cautious Wall Street backdrop demands.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!